Proteomics International Laboratories Limited Stock
Equities
PIQ
AU000000PIQ0
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.025 AUD | -0.49% | -2.38% | +14.53% |
Mar. 25 | Proteomics International Signs Agreement with University of Oxford for Endometriosis Study | MT |
Mar. 19 | Proteomics Says PromarkerD's US Launch Delayed | MT |
Sales 2024 * | 2.8M 1.85M | Sales 2025 * | 5.9M 3.89M | Capitalization | 134M 88.56M |
---|---|---|---|---|---|
Net income 2024 * | -7M -4.62M | Net income 2025 * | -5M -3.3M | EV / Sales 2024 * | 45.9 x |
Net cash position 2024 * | 5.7M 3.76M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 22.7 x |
P/E ratio 2024 * |
-18.3
x | P/E ratio 2025 * |
-25
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.87% |
1 day | -0.49% | ||
1 week | -2.38% | ||
Current month | -5.96% | ||
1 month | -17.34% | ||
3 months | +2.50% | ||
6 months | +11.41% | ||
Current year | +14.53% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 14-06-08 | |
Jacqueline Gray
DFI | Director of Finance/CFO | - | 21-07-11 |
Kirsten Peters
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul House
BRD | Director/Board Member | - | 17-11-21 |
Robyn Elliott
BRD | Director/Board Member | 63 | 21-11-15 |
Founder | - | 14-06-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.025 | -0.49% | 73,823 |
24-05-09 | 1.03 | -0.96% | 125,246 |
24-05-08 | 1.04 | -1.42% | 93,229 |
24-05-07 | 1.055 | -3.21% | 236,073 |
24-05-06 | 1.09 | +3.81% | 219,731 |
Delayed Quote Australian S.E., May 10, 2024 at 02:10 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.53% | 88.59M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- PIQ Stock